| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/06/2022 | 28.15% | Wells Fargo | → $28 | Initiates Coverage On | → Overweight |
| 11/02/2022 | -26.77% | Morgan Stanley | $17 → $16 | Maintains | Underweight |
| 10/20/2022 | 41.88% | JP Morgan | $34 → $31 | Maintains | Overweight |
| 10/18/2022 | -22.2% | Truist Securities | $23 → $17 | Maintains | Hold |
| 09/19/2022 | 28.15% | Piper Sandler | $20 → $28 | Upgrades | Neutral → Overweight |
| 09/08/2022 | 46.45% | Goldman Sachs | $25 → $32 | Maintains | Buy |
| 09/06/2022 | 41.88% | Guggenheim | $24 → $31 | Maintains | Buy |
| 08/18/2022 | -31.35% | Morgan Stanley | $17 → $15 | Downgrades | Equal-Weight → Underweight |
| 08/11/2022 | 9.84% | Credit Suisse | $20 → $24 | Maintains | Outperform |
| 08/10/2022 | 5.26% | Truist Securities | $13 → $23 | Maintains | Hold |
| 08/10/2022 | 14.42% | Goldman Sachs | $18 → $25 | Maintains | Buy |
| 08/10/2022 | 0.69% | Barclays | $20 → $22 | Maintains | Overweight |
| 08/08/2022 | 51.03% | JP Morgan | $28 → $33 | Maintains | Overweight |
| 08/05/2022 | -8.47% | Barclays | → $20 | Initiates Coverage On | → Overweight |
| 07/25/2022 | -26.77% | Credit Suisse | $21 → $16 | Maintains | Outperform |
| 07/20/2022 | 28.15% | JP Morgan | $26 → $28 | Maintains | Overweight |
| 07/19/2022 | -35.93% | Piper Sandler | $10 → $14 | Maintains | Neutral |
| 07/14/2022 | -40.5% | Truist Securities | $8 → $13 | Maintains | Hold |
| 06/29/2022 | -31.35% | Morgan Stanley | $14 → $15 | Maintains | Equal-Weight |
| 06/13/2022 | -35.93% | Morgan Stanley | $17 → $14 | Maintains | Equal-Weight |
| 05/23/2022 | -17.62% | Northland Capital Markets | → $18 | Initiates Coverage On | → Outperform |
| 05/16/2022 | -3.89% | Credit Suisse | $22 → $21 | Maintains | Outperform |
| 05/11/2022 | -17.62% | Goldman Sachs | $20 → $18 | Maintains | Buy |
| 05/11/2022 | -67.96% | Roth Capital | $25 → $7 | Downgrades | Buy → Neutral |
| 05/10/2022 | -22.2% | Morgan Stanley | $18 → $17 | Maintains | Equal-Weight |
| 05/02/2022 | -35.93% | Truist Securities | → $14 | Assumes | → Hold |
| 04/19/2022 | 37.3% | JP Morgan | $33 → $30 | Maintains | Overweight |
| 04/07/2022 | -17.62% | Guggenheim | → $18 | Upgrades | Neutral → Buy |
| 04/06/2022 | -17.62% | Guggenheim | → $18 | Upgrades | Neutral → Buy |
| 01/24/2022 | -35.93% | Truist Securities | $27 → $14 | Maintains | Hold |
| 01/13/2022 | -17.62% | Morgan Stanley | $21 → $18 | Maintains | Equal-Weight |
| 01/10/2022 | 9.84% | Goldman Sachs | $27 → $24 | Maintains | Buy |
| 12/02/2021 | -3.89% | Morgan Stanley | $20 → $21 | Maintains | Equal-Weight |
| 10/20/2021 | -31.35% | Barclays | $16 → $15 | Downgrades | Equal-Weight → Underweight |
| 10/20/2021 | — | Guggenheim | Downgrades | Buy → Neutral | |
| 10/15/2021 | 5.26% | Truist Securities | → $23 | Initiates Coverage On | → Hold |
| 09/08/2021 | -8.47% | Morgan Stanley | $19 → $20 | Maintains | Equal-Weight |
| 08/10/2021 | 14.42% | Roth Capital | → $25 | Upgrades | Neutral → Buy |
| 07/20/2021 | — | Barclays | Upgrades | Underweight → Equal-Weight | |
| 05/24/2021 | -31.35% | Barclays | $16 → $15 | Maintains | Underweight |
| 05/14/2021 | -13.04% | Morgan Stanley | $30 → $19 | Maintains | Equal-Weight |
| 05/13/2021 | 41.88% | Credit Suisse | $42 → $31 | Upgrades | Neutral → Outperform |
| 05/12/2021 | 14.42% | Roth Capital | $53 → $25 | Downgrades | Buy → Neutral |
| 05/12/2021 | -26.77% | Barclays | $32 → $16 | Downgrades | Overweight → Underweight |
| 05/12/2021 | 23.57% | Piper Sandler | $53 → $27 | Downgrades | Overweight → Neutral |
| 04/22/2021 | 46.45% | Barclays | $40 → $32 | Upgrades | Equal-Weight → Overweight |
| 04/16/2021 | 96.8% | UBS | → $43 | Upgrades | Neutral → Buy |
| 03/29/2021 | 37.3% | Morgan Stanley | → $30 | Upgrades | Underweight → Equal-Weight |
| 03/10/2021 | 51.03% | Morgan Stanley | $40 → $33 | Maintains | Underweight |
| 01/20/2021 | 92.22% | Credit Suisse | $37 → $42 | Maintains | Neutral |
| 01/08/2021 | 174.6% | Piper Sandler | → $60 | Initiates Coverage On | → Overweight |
| 12/09/2020 | 87.64% | JP Morgan | $38 → $41 | Upgrades | Neutral → Overweight |
| 11/09/2020 | 69.34% | Credit Suisse | → $37 | Initiates Coverage On | → Neutral |
| 11/09/2020 | 108.24% | Cowen & Co. | → $45.5 | Initiates Coverage On | → Market Perform |
| 11/09/2020 | 110.53% | Barclays | → $46 | Initiates Coverage On | → Equal-Weight |
| 11/09/2020 | — | Morgan Stanley | Initiates Coverage On | → Underweight | |
| 11/09/2020 | 73.91% | JP Morgan | → $38 | Initiates Coverage On | → Neutral |
| 07/12/2019 | 119.68% | JP Morgan | $29 → $48 | Downgrades | Overweight → Neutral |
| 07/08/2019 | 119.68% | Cantor Fitzgerald | $34 → $48 | Downgrades | Overweight → Neutral |
| 06/18/2019 | 119.68% | SVB Leerink | $32 → $48 | Downgrades | Outperform → Market Perform |
| 01/17/2019 | — | Leerink Swann | Initiates Coverage On | → Outperform | |
| 01/15/2019 | 37.3% | Cantor Fitzgerald | → $30 | Initiates Coverage On | → Overweight |
| 12/13/2018 | -8.47% | Goldman Sachs | → $20 | Initiates Coverage On | → Neutral |
| 06/28/2018 | 51.03% | Wells Fargo | $31 → $33 | Maintains | Outperform |
| 06/25/2018 | 18.99% | Cantor Fitzgerald | $24 → $26 | Maintains | Overweight |
| 02/07/2018 | -8.47% | Leerink Swann | $19 → $20 | Maintains | Outperform |
| 02/07/2018 | 5.26% | Stifel | $20 → $23 | Maintains | Buy |
| 01/22/2018 | — | Leerink Swann | Upgrades | Market Perform → Outperform |
What is the target price for Array Technologies (ARRY)?
The latest price target for Array Technologies (NASDAQ: ARRY) was reported by Wells Fargo on December 6, 2022. The analyst firm set a price target for $28.00 expecting ARRY to rise to within 12 months (a possible 28.15% upside). 32 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Array Technologies (ARRY)?
The latest analyst rating for Array Technologies (NASDAQ: ARRY) was provided by Wells Fargo, and Array Technologies initiated their overweight rating.
When is the next analyst rating going to be posted or updated for Array Technologies (ARRY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Array Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Array Technologies was filed on December 6, 2022 so you should expect the next rating to be made available sometime around December 6, 2023.
Is the Analyst Rating Array Technologies (ARRY) correct?
While ratings are subjective and will change, the latest Array Technologies (ARRY) rating was a initiated with a price target of $0.00 to $28.00. The current price Array Technologies (ARRY) is trading at is $21.85, which is within the analyst's predicted range.